| PERIOD ENDING | 31-Mar-09 | | Total Revenue | 29,314 | | Cost of Revenue | 18,203 | | | Gross Profit | 11,111 | | | Operating Expenses | | Research Development | 1,284 | | Selling General and Administrative | 2,498 | | Non Recurring |
-
| | Others |
-
| | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 7,329 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (308) | | Earnings Before Interest And Taxes | 7,021 | | Interest Expense | 113 | | Income Before Tax | 6,908 | | Income Tax Expense | 1,591 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 5,317 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 5,317 | | Preferred Stock And Other Adjustments | (530) | | | Net Income Applicable To Common Shares | $4,787 |
|
0.28% Nasdaq 
0.16%
Income Statement
